{"hands_on_practices": [{"introduction": "A key physical examination finding in significant pericardial effusion is pulsus paradoxus, an exaggerated drop in systolic blood pressure during inspiration. This exercise provides a hands-on opportunity to quantify this phenomenon using data from a manual sphygmomanometer, bridging the gap between a bedside clinical skill and its underlying cardiorespiratory physiology. By calculating the pressure difference, you will solidify your understanding of how pericardial constraint amplifies normal respiratory-hemodynamic interactions and learn to recognize a clinically significant finding. [@problem_id:5188044]", "problem": "An eight-year-old child with suspected pericardial effusion due to acute pericarditis is evaluated for pulsus paradoxus using a manual sphygmomanometer and auscultation of Korotkoff sounds over the brachial artery. The physiology of pulsus paradoxus is grounded in respiratory-hemodynamic coupling: during normal inspiration, a fall in intrathoracic pressure augments right ventricular filling, transiently reduces left ventricular filling due to interventricular dependence, and reduces left ventricular stroke volume, causing a small drop in systemic systolic arterial pressure. When pericardial constraint is present, the inspiratory decrease in left ventricular stroke volume is amplified, and the inspiratory fall in systemic systolic arterial pressure can exceed $10$ mmHg.\n\nIn the sphygmomanometer-based method for quantifying pulsus paradoxus, the cuff pressure is slowly lowered from above systolic pressure while the clinician notes two distinct thresholds:\n- When cuff pressure is at a level where Korotkoff sounds are heard only during expiration but disappear during inspiration, denote this pressure as $P_{\\text{exp-only}}$.\n- When the cuff pressure is further lowered to the point where Korotkoff sounds are heard continuously throughout the respiratory cycle (both inspiration and expiration), denote this pressure as $P_{\\text{all-phases}}$.\n\nBy definition, the magnitude of pulsus paradoxus, $\\Delta P$, equals the difference between the maximal expiratory systolic pressure and the minimal inspiratory systolic pressure over the respiratory cycle. Under the measurement technique described, $P_{\\text{exp-only}}$ approximates the expiratory maximal systolic arterial pressure and $P_{\\text{all-phases}}$ approximates the inspiratory minimal systolic arterial pressure, so $\\Delta P$ can be computed using these two cuff pressures.\n\nDuring the patient’s measurement, the following were recorded:\n- $P_{\\text{exp-only}} = 110$ mmHg,\n- $P_{\\text{all-phases}} = 96$ mmHg.\n\nUsing first principles of the respiratory-hemodynamic mechanism and the definitions above, formulate an expression for $\\Delta P$ in terms of $P_{\\text{exp-only}}$ and $P_{\\text{all-phases}}$, and compute its value. Express your final answer in mmHg. No rounding is required. Additionally, in your reasoning, comment on whether a measured inspiratory drop of $14$ mmHg meets the commonly used clinical threshold for clinically significant pulsus paradoxus in children.", "solution": "The principles of this problem are rooted in cardiovascular physiology and the clinical measurement of arterial blood pressure. We begin by validating the problem statement.\n\n### Step 1: Extract Givens\n- A patient is an eight-year-old child with suspected pericardial effusion.\n- The condition of interest is pulsus paradoxus.\n- The physiological basis is respiratory-hemodynamic coupling, where inspiration normally causes a small drop in systemic systolic arterial pressure, a phenomenon amplified by pericardial constraint.\n- A clinically significant pulsus paradoxus is defined as an inspiratory fall in systemic systolic arterial pressure that exceeds $10$ mmHg.\n- A manual sphygmomanometer is used for measurement.\n- $P_{\\text{exp-only}}$ is the cuff pressure where Korotkoff sounds are heard only during expiration.\n- $P_{\\text{all-phases}}$ is the cuff pressure where Korotkoff sounds are heard continuously throughout the respiratory cycle.\n- The magnitude of pulsus paradoxus, $\\Delta P$, is defined as the difference between the maximal expiratory systolic pressure and the minimal inspiratory systolic pressure.\n- The measurement approximations are given: $P_{\\text{exp-only}}$ approximates the maximal expiratory systolic pressure, and $P_{\\text{all-phases}}$ approximates the minimal inspiratory systolic pressure.\n- The recorded data are: $P_{\\text{exp-only}} = 110$ mmHg and $P_{\\text{all-phases}} = 96$ mmHg.\n- The task is to formulate an expression for $\\Delta P$, compute its value, and comment on its clinical significance.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded. The description of the physiology of pulsus paradoxus, the measurement technique using a sphygmomanometer, the definition of $\\Delta P$, and the clinical threshold for significance are all consistent with established medical and physiological principles. The problem is well-posed, as all necessary definitions and data are provided to arrive at a unique solution. The language is objective and precise. The data provided ($110$ mmHg and $96$ mmHg) are plausible arterial pressures for a pediatric patient. The problem is self-contained and free of contradictions or ambiguities.\n\n### Step 3: Verdict and Action\nThe problem is deemed valid. A solution will be formulated.\n\nThe core task is to determine the magnitude of pulsus paradoxus, $\\Delta P$. By definition, $\\Delta P$ is the difference between the peak systolic arterial pressure during expiration, let's denote it $P_{sys, \\text{exp}}$, and the nadir of systolic arterial pressure during inspiration, denoted $P_{sys, \\text{insp}}$.\n$$\n\\Delta P = P_{sys, \\text{exp}} - P_{sys, \\text{insp}}\n$$\nThe problem describes the clinical procedure for measuring these quantities using a sphygmomanometer. The cuff is inflated to a pressure above the patient's systolic pressure and then slowly deflated.\nThe first pressure noted, $P_{\\text{exp-only}}$, is the level at which the first Korotkoff sounds are audible. Because of the respiratory variation in blood pressure, this first sound corresponds to the highest systolic pressure occurring during the respiratory cycle, which happens during expiration. Therefore, $P_{\\text{exp-only}}$ serves as a direct measurement of the maximal expiratory systolic pressure.\n$$\nP_{sys, \\text{exp}} \\approx P_{\\text{exp-only}}\n$$\nAs the cuff pressure is further reduced, a point is reached where the pressure is low enough to be below even the lowest systolic pressure in the cycle. This lowest systolic pressure occurs during inspiration. At this cuff pressure and below, Korotkoff sounds are heard continuously through both inspiration and expiration. This pressure threshold is defined as $P_{\\text{all-phases}}$. Thus, $P_{\\text{all-phases}}$ serves as a direct measurement of the minimal inspiratory systolic pressure.\n$$\nP_{sys, \\text{insp}} \\approx P_{\\text{all-phases}}\n$$\nSubstituting these measurement-based approximations into the definition of $\\Delta P$, we obtain the formulation for $\\Delta P$ in terms of the given parameters:\n$$\n\\Delta P = P_{\\text{exp-only}} - P_{\\text{all-phases}}\n$$\nThis is the requested expression. Now, we can compute the numerical value for this patient using the provided data:\n- $P_{\\text{exp-only}} = 110 \\text{ mmHg}$\n- $P_{\\text{all-phases}} = 96 \\text{ mmHg}$\n\nSubstituting these values into our expression:\n$$\n\\Delta P = 110 \\text{ mmHg} - 96 \\text{ mmHg} = 14 \\text{ mmHg}\n$$\nThe calculated magnitude of the pulsus paradoxus is $14 \\text{ mmHg}$.\n\nFinally, we are asked to comment on the clinical significance of this result. The problem statement provides the standard clinical threshold: an inspiratory fall in systolic arterial pressure exceeding $10 \\text{ mmHg}$ is considered clinically significant. Our calculated value is $\\Delta P = 14 \\text{ mmHg}$. Since\n$$\n14 \\text{ mmHg} > 10 \\text{ mmHg}\n$$\nthe measured pulsus paradoxus in this patient meets the criterion for being clinically significant. This finding is a key physical examination sign that supports the initial suspicion of pericardial effusion and suggests that the effusion is causing a degree of cardiac tamponade physiology, which is a medical emergency requiring further investigation and possible intervention.", "answer": "$$\\boxed{14}$$", "id": "5188044"}, {"introduction": "When a pericardial effusion is sampled, a critical first step is to classify the fluid as either a transudate or an exudate to narrow the differential diagnosis. This practice challenges you to apply the well-known Light's criteria, originally developed for pleural fluid, to a pericardial fluid sample, requiring you to perform the necessary calculations based on provided lab values. More importantly, this exercise pushes you to think like a clinician-scientist by critically evaluating the limitations of applying these criteria to the unique biochemical environment of the pericardial space. [@problem_id:5188037]", "problem": "A $12$-year-old previously healthy child presents with $3$ days of pleuritic chest pain, fever, and tachycardia. Examination reveals a pericardial friction rub and pulsus paradoxus of $12$ mmHg. Echocardiography shows a moderate circumferential pericardial effusion without tamponade physiology. Laboratory studies: serum total protein $6.2$ g/dL, serum albumin $3.9$ g/dL, serum lactate dehydrogenase (LDH) $240$ U/L with an upper limit of normal (ULN) of $300$ U/L, C-reactive protein $56$ mg/L, high-sensitivity troponin I $120$ ng/L. Pericardial fluid analysis: total protein $3.6$ g/dL, albumin $2.5$ g/dL, LDH $400$ U/L, glucose $78$ mg/dL, white blood cells $2{,}200$ per $\\mu$L with $75\\%$ lymphocytes, negative Gram stain. There is clinical concern for viral myopericarditis.\n\nExudates and transudates can be distinguished based on microvascular fluid flux and solute reflection principles. Starting from Starling’s law of transvascular flux, $$J_v = K_f\\big[(P_c - P_i) - \\sigma(\\pi_c - \\pi_i)\\big],$$ where $J_v$ is volume flux, $K_f$ is filtration coefficient, $P_c$ and $P_i$ are capillary and interstitial hydrostatic pressures, $\\pi_c$ and $\\pi_i$ are capillary and interstitial oncotic pressures, and $\\sigma$ is the protein reflection coefficient, explain how an inflammatory pericardial process alters $K_f$ and $\\sigma$ to yield an exudate and how hydrostatic or hypo-oncotic states yield a transudate. Then, critically assess the practice of classifying pericardial effusions as exudate versus transudate by adapting thresholds originally validated for pleural fluid. Without listing any specific criteria in the prompt, use the provided data to compute the relevant ratios and thresholds as you would for pleural Light’s criteria, and integrate pathophysiology to judge classification and its limitations in pericardial disease, especially in pediatrics.\n\nWhich option best captures a correct classification based on adapted pleural thresholds and a rigorous critique of their limitations in pericardial effusions?\n\nA. Applying pleural thresholds to these pericardial measurements yields an exudate: the pericardial-to-serum protein ratio exceeds the conventional exudate cutoff and pericardial LDH surpasses both the LDH ratio and the fraction of serum ULN benchmarks; however, this adaptation has poor specificity in pericardial disease because baseline pericardial protein and LDH are higher even in hydrostatic states, so clinical context and pericardial-specific tests must supplement interpretation.\n\nB. The effusion is transudative because the serum-to-pericardial albumin gradient exceeds the pleural transudate cutoff, a rule that is robustly validated for pericardial fluid; Light’s criteria should not be used in the pericardial space.\n\nC. The effusion is transudative because the pericardial fluid LDH-to-serum LDH ratio is below the conventional pleural exudate cutoff, which indicates preserved membrane selectivity and hydrostatic filtration typical of heart failure.\n\nD. Laboratory thresholds cannot classify pericardial effusions; only cytology determines exudate versus transudate, so ratios and LDH are not informative for pericardial disease.", "solution": "The task is to evaluate a clinical case of pediatric myopericarditis with a pericardial effusion. This requires a three-part analysis: first, a fundamental explanation of transudate versus exudate formation based on Starling's law; second, the application of adapted clinical criteria (Light's criteria) to classify the given pericardial effusion; and third, a critical appraisal of the validity and limitations of this classification method.\n\n### Part 1: Pathophysiological Basis of Transudates and Exudates\n\nThe formation of fluid in potential spaces like the pericardium is governed by the principles of transvascular fluid exchange, quantified by Starling's law:\n$$ J_v = K_f\\big[(P_c - P_i) - \\sigma(\\pi_c - \\pi_i)\\big] $$\nwhere $J_v$ is the net volume flux across the capillary wall, $K_f$ is the filtration coefficient representing the hydraulic conductivity of the membrane, $P_c$ and $P_i$ are the hydrostatic pressures in the capillary and the interstitium (pericardial space), respectively, $\\pi_c$ and $\\pi_i$ are the oncotic pressures in the capillary and interstitium, and $\\sigma$ is the reflection coefficient, which describes the capillary's impermeability to proteins (where $\\sigma = 1$ is complete impermeability and $\\sigma = 0$ is free permeability).\n\nA **transudate** forms when the capillary membrane remains intact, but the balance of Starling forces is disrupted. This corresponds to a state where the membrane parameters $K_f$ and $\\sigma$ are essentially normal (low $K_f$, high $\\sigma \\approx 1$). The accumulation of fluid results from either:\n1.  An increase in capillary hydrostatic pressure ($P_c$), as seen in congestive heart failure. This pushes more fluid out of the capillary.\n2.  A decrease in capillary oncotic pressure ($\\pi_c$), as seen in hypoalbuminemic states like nephrotic syndrome or cirrhosis. This reduces the force retaining fluid within the capillary.\nIn both scenarios, because the membrane is not leaky to protein ($\\sigma$ is high), the filtered fluid is an ultrafiltrate of plasma, characterized by low protein and low cellular content.\n\nAn **exudate** forms as a result of an inflammatory or malignant process that damages the capillary endothelium. This directly alters the membrane's properties:\n1.  Inflammatory mediators cause endothelial cell contraction and widening of inter-endothelial junctions, leading to a significant **increase in the filtration coefficient ($K_f$)**.\n2.  The larger gaps in the endothelium make it leaky to proteins and other large molecules, which is represented by a **decrease in the reflection coefficient ($\\sigma$)**.\nWith a lower $\\sigma$ and higher $K_f$, protein-rich plasma and inflammatory cells can readily leak into the pericardial space. This results in a fluid with high protein content, high lactate dehydrogenase (LDH, an intracellular enzyme released from damaged cells), and a high number of inflammatory cells. The provided clinical context—fever, pleuritic chest pain, elevated C-reactive protein ($56$ mg/L), and elevated troponin ($120$ ng/L)—strongly indicates an inflammatory process (myopericarditis), which is expected to produce an exudate.\n\n### Part 2: Classification using Adapted Light's Criteria\n\nLight's criteria, originally validated for pleural effusions, are often adapted to classify effusions in other serous cavities, including the pericardium. An effusion is classified as an exudate if it meets at least one of the following three criteria:\n1.  Fluid protein / Serum protein ratio $> 0.5$\n2.  Fluid LDH / Serum LDH ratio $> 0.6$\n3.  Fluid LDH $> \\frac{2}{3}$ of the upper limit of normal (ULN) for serum LDH.\n\nLet us apply these criteria using the provided laboratory data:\n*   Serum total protein: $6.2$ g/dL\n*   Pericardial fluid total protein: $3.6$ g/dL\n*   Serum LDH: $240$ U/L\n*   Pericardial fluid LDH: $400$ U/L\n*   Serum LDH ULN: $300$ U/L\n\n**Criterion 1: Protein Ratio**\n$$ \\text{Ratio}_{\\text{protein}} = \\frac{\\text{Pericardial Fluid Protein}}{\\text{Serum Protein}} = \\frac{3.6 \\text{ g/dL}}{6.2 \\text{ g/dL}} \\approx 0.58 $$\nSince $0.58 > 0.5$, this criterion for an exudate is **met**.\n\n**Criterion 2: LDH Ratio**\n$$ \\text{Ratio}_{\\text{LDH}} = \\frac{\\text{Pericardial Fluid LDH}}{\\text{Serum LDH}} = \\frac{400 \\text{ U/L}}{240 \\text{ U/L}} = \\frac{5}{3} \\approx 1.67 $$\nSince $1.67 > 0.6$, this criterion for an exudate is **met**.\n\n**Criterion 3: Fluid LDH vs. ULN**\nThe threshold value is $\\frac{2}{3} \\times \\text{ULN}_{\\text{serum LDH}} = \\frac{2}{3} \\times 300 \\text{ U/L} = 200 \\text{ U/L}$.\nThe pericardial fluid LDH is $400$ U/L.\nSince $400 \\text{ U/L} > 200 \\text{ U/L}$, this criterion for an exudate is also **met**.\n\nAs all three criteria are met, the effusion is definitively classified as an **exudate** according to adapted Light's criteria. This aligns with the clinical suspicion of inflammatory myopericarditis.\n\n### Part 3: Critical Assessment and Option Evaluation\n\nThe final part of the task is to critique the use of these criteria for pericardial fluid. The primary issue is that normal pericardial fluid itself has a higher protein and LDH concentration than normal pleural fluid. It is not a simple plasma ultrafiltrate but more akin to an interstitial fluid filtrate. Consequently, transudative pericardial effusions (e.g., from heart failure) may have protein and LDH levels high enough to meet the exudative cutoffs defined by Light's criteria. This leads to the misclassification of some transudates as exudates, meaning the criteria have **poor specificity** for pericardial effusions, although their sensitivity for detecting true exudates is high. Therefore, clinical context is paramount, and other tests may be required in ambiguous cases.\n\n**Option A: Applying pleural thresholds to these pericardial measurements yields an exudate: the pericardial-to-serum protein ratio exceeds the conventional exudate cutoff and pericardial LDH surpasses both the LDH ratio and the fraction of serum ULN benchmarks; however, this adaptation has poor specificity in pericardial disease because baseline pericardial protein and LDH are higher even in hydrostatic states, so clinical context and pericardial-specific tests must supplement interpretation.**\nThis option correctly states that the application of adapted Light's criteria classifies the fluid as an exudate. It correctly identifies that all three benchmarks are surpassed. Critically, it provides an accurate and nuanced critique of the method, pointing out the poor specificity due to the higher baseline protein/LDH in pericardial fluid and emphasizing the importance of clinical context. This aligns perfectly with the analysis.\n**Verdict: Correct**\n\n**Option B: The effusion is transudative because the serum-to-pericardial albumin gradient exceeds the pleural transudate cutoff, a rule that is robustly validated for pericardial fluid; Light’s criteria should not be used in the pericardial space.**\nThis option makes several errors. First, it incorrectly classifies the effusion as transudative, contrary to both the calculations and the clinical picture. Second, the serum-albumin gradient (serum albumin minus fluid albumin) is a criterion primarily used for ascites, not pericardial fluid, and it is not \"robustly validated\" for this purpose. The calculated gradient is $3.9 - 2.5 = 1.4$ g/dL, which, if extrapolated from ascites criteria, would actually suggest a transudate (from portal hypertension); however, this extrapolation is inappropriate and leads to a conclusion that contradicts all other data.\n**Verdict: Incorrect**\n\n**Option C: The effusion is transudative because the pericardial fluid LDH-to-serum LDH ratio is below the conventional pleural exudate cutoff, which indicates preserved membrane selectivity and hydrostatic filtration typical of heart failure.**\nThis option is factually incorrect. It claims the effusion is transudative based on the LDH ratio being below the cutoff. As calculated above, the LDH ratio is approximately $1.67$, which is substantially *above* the cutoff of $0.6$. The rest of the statement is a description of a transudate that is predicated on a false calculation.\n**Verdict: Incorrect**\n\n**Option D: Laboratory thresholds cannot classify pericardial effusions; only cytology determines exudate versus transudate, so ratios and LDH are not informative for pericardial disease.**\nThis statement is too absolute and partially false. While laboratory thresholds have limitations, they are not useless or \"not informative.\" They are a key part of the diagnostic workup. Furthermore, cytology is used to detect malignant cells; it does not distinguish an inflammatory exudate from a transudate. The distinction between exudate and transudate is fundamentally biochemical (protein, LDH) and cellular (cell count and differential), not solely cytological.\n**Verdict: Incorrect**", "answer": "$$\\boxed{A}$$", "id": "5188037"}, {"introduction": "The Frank-Starling principle is fundamental to understanding how the heart modulates its output, but its function is profoundly altered in myocarditis. This problem utilizes a quantitative model to dissect the complex pathophysiology, allowing you to calculate the impact of decreased contractility, increased myocardial stiffness, and external pericardial constraint on stroke volume. Working through this hypothetical scenario provides a powerful, tangible sense of how different pathological insults combine to impair cardiac performance, moving beyond qualitative descriptions to a quantitative appreciation of heart failure. [@problem_id:5188094]", "problem": "A $12$-year-old child with biopsy-proven acute myocarditis and a moderate inflammatory pericardial effusion is monitored in the intensive care unit. You are asked to quantify the effect of this acute myocardial inflammation and pericardial constraint on the Left Ventricular (LV) Stroke Volume (SV) at a fixed intracavitary LV End-Diastolic Pressure (EDP). Use the Frank–Starling principle that SV increases with effective myocardial fiber stretch, which is determined by the LV transmural filling pressure.\n\nAssume the following physiologically grounded model near the operating point, justified as a local linearization of the Frank–Starling relationship: SV varies proportionally with the effective preload above a diastolic threshold. Let the effective preload be the LV transmural pressure $P_{\\mathrm{tm}}$, given by $P_{\\mathrm{tm}} = \\mathrm{EDP} - P_{\\mathrm{peri}}$, where $P_{\\mathrm{peri}}$ is the pericardial pressure. Let the local relation be\nSV increases linearly with $P_{\\mathrm{tm}}$ above a diastolic threshold $P_{0}$, with proportionality (local gain) $s$.\n\nAt baseline (no inflammation or effusion), the parameters near the operating point are:\n- Intracavitary LV EDP $=$ $12$ mmHg,\n- Pericardial pressure $P_{\\mathrm{peri}} = 0$ mmHg,\n- Diastolic threshold $P_{0} = 2$ mmHg,\n- Local Frank–Starling gain $s = 7$ mL/mmHg.\n\nAcute myocarditis and pericardial effusion cause:\n- A $30\\%$ reduction in contractility, reducing the local gain to $(1 - 0.30)\\,s$,\n- Myocardial edema that raises the diastolic threshold by $\\Delta P_{0} = 1$ mmHg (so the threshold becomes $P_{0} + \\Delta P_{0}$),\n- An increase in pericardial pressure to $P_{\\mathrm{peri}} = 4$ mmHg.\n\nAssuming the intracavitary LV EDP remains fixed at $12$ mmHg, use these assumptions to compute the expected LV Stroke Volume under acute myocarditis with effusion at that same measured EDP. Express the final stroke volume in mL. Round your answer to three significant figures.", "solution": "The problem is scientifically and mathematically well-posed and contains sufficient information to determine a unique solution. We begin by formalizing the relationship provided for Left Ventricular (LV) Stroke Volume ($\\mathrm{SV}$).\n\nThe problem states that $\\mathrm{SV}$ increases linearly with the LV transmural pressure, $P_{\\mathrm{tm}}$, above a diastolic threshold, $P_{0}$. The proportionality constant, or local gain, is given as $s$. This can be expressed by the equation:\n$$ \\mathrm{SV} = s \\times (P_{\\mathrm{tm}} - P_{0}) $$\nThis equation is valid only when $P_{\\mathrm{tm}} > P_{0}$; otherwise, we can assume $\\mathrm{SV} = 0$.\n\nThe transmural pressure, $P_{\\mathrm{tm}}$, is defined as the difference between the intracavitary LV End-Diastolic Pressure ($\\mathrm{EDP}$) and the surrounding pericardial pressure, $P_{\\mathrm{peri}}$:\n$$ P_{\\mathrm{tm}} = \\mathrm{EDP} - P_{\\mathrm{peri}} $$\nSubstituting this definition into the $\\mathrm{SV}$ equation gives the full model:\n$$ \\mathrm{SV} = s \\times ((\\mathrm{EDP} - P_{\\mathrm{peri}}) - P_{0}) $$\n\nThe goal is to compute the $\\mathrm{SV}$ under the conditions of acute myocarditis and pericardial effusion. We must first determine the values of the parameters $s$, $P_{0}$, and $P_{\\mathrm{peri}}$ for this acute state. Let us denote the baseline parameters with a subscript 'base' and the acute state parameters with a subscript 'acute'.\n\nThe baseline parameters are given as:\n- Baseline gain: $s_{\\mathrm{base}} = 7 \\text{ mL/mmHg}$\n- Baseline diastolic threshold: $P_{0, \\mathrm{base}} = 2 \\text{ mmHg}$\n- Baseline pericardial pressure: $P_{\\mathrm{peri, base}} = 0 \\text{ mmHg}$\n- Baseline LV EDP: $\\mathrm{EDP}_{\\mathrm{base}} = 12 \\text{ mmHg}$\n\nThe problem describes the changes due to the acute pathology:\n1.  The local gain $s$ is reduced by $30\\%$. The new gain, $s_{\\mathrm{acute}}$, is:\n    $$ s_{\\mathrm{acute}} = (1 - 0.30) \\times s_{\\mathrm{base}} = 0.70 \\times 7 \\text{ mL/mmHg} = 4.9 \\text{ mL/mmHg} $$\n2.  The diastolic threshold $P_{0}$ is raised by $\\Delta P_{0} = 1 \\text{ mmHg}$. The new threshold, $P_{0, \\mathrm{acute}}$, is:\n    $$ P_{0, \\mathrm{acute}} = P_{0, \\mathrm{base}} + \\Delta P_{0} = 2 \\text{ mmHg} + 1 \\text{ mmHg} = 3 \\text{ mmHg} $$\n3.  The pericardial pressure increases to $P_{\\mathrm{peri, acute}} = 4 \\text{ mmHg}$.\n\nThe problem states that the intracavitary LV EDP is held fixed at its baseline value:\n$$ \\mathrm{EDP}_{\\mathrm{acute}} = 12 \\text{ mmHg} $$\n\nNow, we can calculate the transmural pressure in the acute state, $P_{\\mathrm{tm, acute}}$:\n$$ P_{\\mathrm{tm, acute}} = \\mathrm{EDP}_{\\mathrm{acute}} - P_{\\mathrm{peri, acute}} = 12 \\text{ mmHg} - 4 \\text{ mmHg} = 8 \\text{ mmHg} $$\n\nBefore applying the $\\mathrm{SV}$ formula, we must verify that the condition $P_{\\mathrm{tm, acute}} > P_{0, \\mathrm{acute}}$ is met.\n$$ 8 \\text{ mmHg} > 3 \\text{ mmHg} $$\nThe condition is satisfied, so we can proceed with the calculation of $\\mathrm{SV}_{\\mathrm{acute}}$.\n\nSubstituting the parameter values for the acute state into the model equation:\n$$ \\mathrm{SV}_{\\mathrm{acute}} = s_{\\mathrm{acute}} \\times (P_{\\mathrm{tm, acute}} - P_{0, \\mathrm{acute}}) $$\n$$ \\mathrm{SV}_{\\mathrm{acute}} = 4.9 \\frac{\\text{mL}}{\\text{mmHg}} \\times (8 \\text{ mmHg} - 3 \\text{ mmHg}) $$\n$$ \\mathrm{SV}_{\\mathrm{acute}} = 4.9 \\frac{\\text{mL}}{\\text{mmHg}} \\times (5 \\text{ mmHg}) $$\n$$ \\mathrm{SV}_{\\mathrm{acute}} = 24.5 \\text{ mL} $$\n\nThe problem requires the answer to be rounded to three significant figures. The calculated value $24.5$ already has three significant figures ($2$, $4$, and $5$), so no further rounding is necessary.\nThe expected LV Stroke Volume under the specified pathological conditions is $24.5$ mL.", "answer": "$$\\boxed{24.5}$$", "id": "5188094"}]}